Results 181 to 190 of about 702,273 (272)
Abstract Background To assess the dose‐sparing capabilities of a yaw‐limited volumetric modulated arc therapy (YL_VMAT) beam setup for adjacent organs at risk (OAR) in comparison with 3D‐conventional radiation therapy (3D‐CRT), intensity‐modulated radiation therapy (IMRT) and conventional VMAT for radiation therapy in left‐sided breast cancer patients.
Gerhard Pollul+4 more
wiley +1 more source
Advances in Surface-Enhanced Raman Spectroscopy for Therapeutic Drug Monitoring. [PDF]
Lai H, Wang X, Qi M, Huang H, Yu B.
europepmc +1 more source
Abstract Purpose The dual‐layer multileaf collimator (MLC) in Halcyon adds complexities to the dose calculation process owing to the variability of dosimetric characteristics with leaf motion. Recently, an enhanced leaf model (ELM) was developed to refine the MLC model in the Eclipse treatment planning system. This study investigates the performance of
Ryohei Miyasaka+6 more
wiley +1 more source
Therapeutic drug monitoring for immune mediated inflammatory diseases. [PDF]
Chanchlani N, Yiu ZZN, Stamp LK, Day AS.
europepmc +1 more source
Adherence Monitoring and Drug Surveillance in Chronic Opioid Therapy [PDF]
Scott M. Fishman+5 more
openalex +1 more source
Closing the gap in plan quality: Leveraging deep‐learning dose prediction for adaptive radiotherapy
Abstract Purpose Balancing quality and efficiency has been a challenge for online adaptive therapy. Most systems start the online re‐optimization with the original planning goals. While some systems allow planners to modify the planning goals, achieving a high‐quality plan within time constraints remains a common barrier.
Sean J. Domal+9 more
wiley +1 more source
Adalimumab Autoantibodies in Uveitis Patients: Do We Need Routine Drug Monitoring? [PDF]
Zur Bonsen LS+4 more
europepmc +1 more source
Implementation of a drug therapy monitoring clinic in a primary-care setting [PDF]
Jillmarie K. Yanchick
openalex +1 more source
Abstract This study evaluates various radiotherapy techniques for treating metastatic brain tumor (BT), focusing on non‐coplanar volumetric modulated arc radiotherapy (NC‐VMAT), coplanar VMAT (C‐VMAT), Helical TomoTherapy (HT), CyberKnife (CK), Gamma Knife (GK), and ZAP‐X.
Toshihiro Suzuki+9 more
wiley +1 more source